AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Biotechnology

Healthcare
$5.82 +2.48%

+$0.25 today

Market cap
$286.62M
Beta
2.62
P/E (TTM)
-7.1
EPS (TTM)
-$1.28
52W Low $8.75High $17.45

Volume 0.13M

Average 0.14M

AGMB Accumulated OCI

Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.

AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB

Accumulated OCI · Q3 FY2025 · quarter ended Sep 2025

Accumulated OCI of -€966K in Q3 FY2025

Q3 FY2025 Accumulated OCI was -€966K.

Context

  • Accumulated OCI amounted to 0.6% of total assets at the end of Q3 FY2025.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2025
-€966K— QoQ
Accumulated OCI past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accumulated OCI history

Currency unavailable · from the balance sheet

No Accumulated OCI data reported for this period type.

Accumulated OCI vs competitors

How AGMB compares with its peers on the latest reported figures

  • Peers report in different currencies, so Accumulated OCI is compared through growth and share of total assets rather than absolute size.
  • Accumulated OCI amounts to 0.6% of total assets for AGMB, versus a peer median of 0.1%.
AGMB Competitors
Accumulated OCI for AGMB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
EQEquillium, Inc.Mar 2026$370K USD-49.4%+68.4%0.6%
ACRSAclaris Therapeutics, Inc.Mar 2026$22K USD-94.9%—0.0%
ANABAnaptysBio, Inc.Mar 2026-$146K USD-190.7%—0.0%
ALMSAlumis Inc. Common StockJun 2026-$683K USD-3204.5%—0.1%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025-€966K EUR——0.6%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding AGMB) —-142.8%+68.4%0.1%

Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Intrinsic Alpha fair value

Locked

Current Price

$5.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.